Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm 2024 May 01;11(3)e200231, L Graille-Avy, C Boutiere, C Rigollet, M Perriguey, A Rico, S Demortiere, P Durozard, F Hilezian, F Vely, P Bertault-Peres, J Pelletier, A Maarouf, B AudoinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.